SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2020 / Cilt: 68 - Sayı: 4

D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis

D-dimer seviyeleri ve COVID-19 şiddeti: Sistematik Derleme ve Metaanaliz

Aydın BALCI
Muhammed Emin DÜZ
Elif MENEKŞE
Pages
353–360
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

D-dimer concentrations were significantly hig-her in severe patients against total COVID-19 patients (SMD: 2.01 μg/mL; 95% CI, 0.25 to 3.77 μg/mL, p= 0.08).Conclusion: We do not know the D-dimer increment mechanism in severe patients yet, but we think that these findings will be useful in the early diag-nosis of severe disease and the first treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Coronavirus disease 2019 (COVID-19) is a fatal and pandemic disease discovered in December 2019 in Wuhan, with lots of asymptomatic cases and a long incubation period.
📊
Key Findings & Data:Materials and Methods: We searched in PubMed, Scopus, and Web of Science using the keywords “D-dimer” and “coronavirus” or “D-dimer” and “COVID-19.” We used Standardized Mean Differences (SMD) to build forest plots of continuous data and assess differences in serum D-dimer concentra-tions between severe and non-severe patients with COVID-19 disease.
💡
Conclusion & Impact:D-dimer concentrations were significantly hig-her in severe patients against total COVID-19 patients (SMD: 2.01 μg/mL; 95% CI, 0.25 to 3.77 μg/mL, p= 0.08).Conclusion: We do not know the D-dimer increment mechanism in severe patients yet, but we think that these findings will be useful in the early diag-nosis of severe disease and the first treatment.
🔬Design:Lab & Field Experiment
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is a fatal and pandemic disease discovered in December 2019 in Wuhan, with lots of asymptomatic cases and a long incubation period. The researchers suggested that high d-dimer levels could predict disease severity, lung complications, and throm-boembolic events before they occur. Materials and Methods: We searched in PubMed, Scopus, and Web of Science using the keywords “D-dimer” and “coronavirus” or “D-dimer” and “COVID-19.” We used Standardized Mean Differences (SMD) to build forest plots of continuous data and assess differences in serum D-dimer concentra-tions between severe and non-severe patients with COVID-19 disease. We evaluated p-value < 0.05 as statistically significant and preferred 95% confi-dence intervals (CIs).Results: The pooled results of all studies revealed that the D-dimer concentra-tions were significantly higher in patients with more severe COVID-19 (SMD: 2.32 μg/mL; 95% CI, 0.72 3.92 μg/mL, p< 0.001). We evaluated severe pati-ents with total D-dimer levels. D-dimer concentrations were significantly hig-her in severe patients against total COVID-19 patients (SMD: 2.01 μg/mL; 95% CI, 0.25 to 3.77 μg/mL, p= 0.08).Conclusion: We do not know the D-dimer increment mechanism in severe patients yet, but we think that these findings will be useful in the early diag-nosis of severe disease and the first treatment.

Özet

Giriş: Koronavirüs hastalığı 2019 (COVID-19), Aralık 2019’da Wuhan’da keşfedilen, çok sayıda asemptomatik vaka ve uzun bir kuluç-ka dönemi ile ölümcül ve pandemik bir hastalıktır. Araştırmacılar, yüksek D-dimer seviyelerinin hastalık şiddetini, akciğer komplikas-yonlarını ve tromboembolik olayları ortaya çıkmadan önce tahmin edebileceğini öne sürdü.Materyal ve Metod: PubMed, Scopus ve Web of Science’ta “D-dimer” ve “koronavirüs” veya “D-dimer” ve “COVID-19” anahtar kelimelerini kullanarak arama yaptık. Sürekli verilerin forest plot analizi ve COVID-19 enfeksiyonlu, şiddetli ve şiddetli olmayan has-talar arasındaki serum D-dimer konsantrasyonlarındaki farklılıkları değerlendirmek için Standart Ortalama Farklılıkları (SMD) kullan-dık. P değerini

🔖

Cite This Article

BALCI, A., DÜZ, M. E., MENEKŞE, E. (2022). D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis. Tüberküloz ve Toraks, Cilt: 68 - Sayı: 4, 353–360. https://ajindex.com/articles/618367

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. ArcGIS. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Johns Hopkins University. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/ index.html#/bda7594740fd40299423467b48e9ecf6 Accessed date: 27 Sept 2020
  2. Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol 2020; 18: 123
  3. European Centre for Disease Prevention and Control. Q & A on COVID-19: Basic facts. Available from: https://www. ecdc.europa.eu/en/covid-19/facts/questions-answersbasic- facts Accessed date: 18 Sept 2020
  4. Liu B, Li M, Zhou Z, Guan X, Xiang YJ. Can we use the interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Autoimmun 2020; 111: 102452
  5. Dolhnikoff M, Duarte-Neto AN, de AlmeidaMonteiro RA, Ferraz da Silva LF, Pierre de Oliveira E, Nascimento Saldiva PH, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost 2020; 18: 1517-9
  6. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and prospects. Blood 2009; 113(13): 2878- 87
  7. Lippi G, Favaloro EJ. D-dimer is associated with the severity of coronavirus disease 2019: A pooled analysis. Thromb Haemost 2020; 120: 876-8
  8. Mouat B, Besutti M, Bouiller K. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Eur Respir J 2020; 56(4): 2001811
  9. Pizzi R, Gini G, Caiano L, Roveda A, Bertù L, Ageno W, et al. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the emergency department for acute respiratory insufficiency. Thromb Res 2020; 196: 209-12
  10. Santotoribio JD, Nuñez-Jurado D, Lepe-Balsalobre E. Evaluation of routine blood tests for diagnosis of suspected coronavirus disease 2019. Clin Lab 2020; 66(9): 200522
  11. Cheng A, Hu L, Wang Y, Huang L, Zhao L, Zhang C, et al. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents 2020; 56(3): 106110
  12. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with COVID‐19. J Thromb Haemost 2020; 18: 1324-9
  13. Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res 2020; 192: 3-8. 1